AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 51 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,557,000 | +710.9% | 337,055 | +394.8% | 0.00% | – |
| Q2 2020 | $192,000 | -1.5% | 68,122 | -14.7% | 0.00% | – |
| Q1 2020 | $195,000 | -86.0% | 79,835 | -70.6% | 0.00% | – |
| Q4 2019 | $1,391,000 | -40.5% | 271,789 | -25.0% | 0.00% | -100.0% |
| Q3 2019 | $2,339,000 | -45.9% | 362,151 | -47.8% | 0.00% | – |
| Q2 2019 | $4,326,000 | – | 694,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|